REGN vs RYAN
Regeneron Pharmaceuticals Inc (REGN) versus Ryan Specialty Group Holdings Inc (RYAN) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Ryan Specialty Group Holdings Inc (RYAN) is a insurance - specialty company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported RYAN revenue for 2024-12-31 was $2.46B. Net income was $229.9M. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
Not investment advice. Open the REGN and RYAN stock pages for the full models.
Not investment advice.